-
1
-
-
67649205149
-
EASL clinical practice guidelines management of cholestatic liver diseases
-
EASL Clinical Practice Guidelines Management of cholestatic liver diseases J Hepatol 51 2009 237 267
-
(2009)
J Hepatol
, vol.51
, pp. 237-267
-
-
-
2
-
-
84890561808
-
Bile formation and secretion
-
J.L. Boyer Bile formation and secretion Compr Physiol 3 2013 1035 1078
-
(2013)
Compr Physiol
, vol.3
, pp. 1035-1078
-
-
Boyer, J.L.1
-
3
-
-
84869852834
-
Current pharmacotherapy for cholestatic liver disease
-
E.J. Carey, and K.D. Lindor Current pharmacotherapy for cholestatic liver disease Expert Opin Pharmacother 13 2012 2473 2484
-
(2012)
Expert Opin Pharmacother
, vol.13
, pp. 2473-2484
-
-
Carey, E.J.1
Lindor, K.D.2
-
4
-
-
84875599882
-
Nuclear receptors as drug targets in cholestatic liver diseases
-
E. Halilbasic, A. Baghdasaryan, and M. Trauner Nuclear receptors as drug targets in cholestatic liver diseases Clin Liver Dis 17 2013 161 189
-
(2013)
Clin Liver Dis
, vol.17
, pp. 161-189
-
-
Halilbasic, E.1
Baghdasaryan, A.2
Trauner, M.3
-
5
-
-
84890562936
-
Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice
-
J. Weerachayaphorn, Y. Luo, A. Mennone, S.J. Soroka, K. Harry, and J.L. Boyer Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice J Hepatol 60 2014 160 166
-
(2014)
J Hepatol
, vol.60
, pp. 160-166
-
-
Weerachayaphorn, J.1
Luo, Y.2
Mennone, A.3
Soroka, S.J.4
Harry, K.5
Boyer, J.L.6
-
6
-
-
68949146859
-
Therapeutic potential of dithiolethiones for hepatic diseases
-
S.C. Brooks 3rd, J.S. Brooks, W.H. Lee, M.G. Lee, and S.G. Kim Therapeutic potential of dithiolethiones for hepatic diseases Pharmacol Ther 124 2009 31 43
-
(2009)
Pharmacol Ther
, vol.124
, pp. 31-43
-
-
Brooks III, S.C.1
Brooks, J.S.2
Lee, W.H.3
Lee, M.G.4
Kim, S.G.5
-
7
-
-
13844292752
-
Oncosis represents the main type of cell death in mouse models of cholestasis
-
P. Fickert, M. Trauner, A. Fuchsbichler, G. Zollner, M. Wagner, and H.U. Marschall Oncosis represents the main type of cell death in mouse models of cholestasis J Hepatol 42 2005 378 385
-
(2005)
J Hepatol
, vol.42
, pp. 378-385
-
-
Fickert, P.1
Trauner, M.2
Fuchsbichler, A.3
Zollner, G.4
Wagner, M.5
Marschall, H.U.6
-
8
-
-
4644238904
-
Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation
-
J.S. Gujral, J. Liu, A. Farhood, and H. Jaeschke Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation Hepatology 40 2004 998 1007
-
(2004)
Hepatology
, vol.40
, pp. 998-1007
-
-
Gujral, J.S.1
Liu, J.2
Farhood, A.3
Jaeschke, H.4
-
9
-
-
10744225137
-
Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation
-
M.H. Schoemaker, W.M. Gommans, L. Conde de la Rosa, M. Homan, P. Klok, and C. Trautwein Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation J Hepatol 39 2003 153 161
-
(2003)
J Hepatol
, vol.39
, pp. 153-161
-
-
Schoemaker, M.H.1
Gommans, W.M.2
De La Rosa, L.C.3
Homan, M.4
Klok, P.5
Trautwein, C.6
-
10
-
-
0036788262
-
Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles
-
P. Fickert, G. Zollner, A. Fuchsbichler, C. Stumptner, A.H. Weiglein, and F. Lammert Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles Gastroenterology 123 2002 1238 1251
-
(2002)
Gastroenterology
, vol.123
, pp. 1238-1251
-
-
Fickert, P.1
Zollner, G.2
Fuchsbichler, A.3
Stumptner, C.4
Weiglein, A.H.5
Lammert, F.6
-
11
-
-
0042825756
-
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice
-
M. Wagner, P. Fickert, G. Zollner, A. Fuchsbichler, D. Silbert, and O. Tsybrovskyy Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice Gastroenterology 125 2003 825 838
-
(2003)
Gastroenterology
, vol.125
, pp. 825-838
-
-
Wagner, M.1
Fickert, P.2
Zollner, G.3
Fuchsbichler, A.4
Silbert, D.5
Tsybrovskyy, O.6
-
12
-
-
0033866538
-
Manometric changes during retrograde biliary infusion in mice
-
S.M. Wiener, R.F. Hoyt Jr., J.R. Deleonardis, R.R. Clevenger, K.R. Jeffries, and K. Nagashima Manometric changes during retrograde biliary infusion in mice Am J Physiol Gastrointest Liver Physiol 279 2000 G49 G66
-
(2000)
Am J Physiol Gastrointest Liver Physiol
, vol.279
-
-
Wiener, S.M.1
Hoyt, Jr.R.F.2
Deleonardis, J.R.3
Clevenger, R.R.4
Jeffries, K.R.5
Nagashima, K.6
-
15
-
-
77951621825
-
Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice
-
A.D. McNeilly, D.P. Macfarlane, E. O'Flaherty, D.E. Livingstone, T. Mitić, and K.M. McConnell Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice J Hepatol 52 2010 705 711
-
(2010)
J Hepatol
, vol.52
, pp. 705-711
-
-
McNeilly, A.D.1
Macfarlane, D.P.2
O'Flaherty, E.3
Livingstone, D.E.4
Mitić, T.5
McConnell, K.M.6
-
16
-
-
84888303010
-
Bile acids trigger cholemic nephropathy in common Bile-Duct-ligated mice
-
10.1002/hep.26599
-
P. Fickert, E. Krones, M.J. Pollheimer, A. Thueringer, T. Moustafa, and D. Silbert Bile acids trigger cholemic nephropathy in common Bile-Duct-ligated mice Hepatology 2013 10.1002/hep.26599
-
(2013)
Hepatology
-
-
Fickert, P.1
Krones, E.2
Pollheimer, M.J.3
Thueringer, A.4
Moustafa, T.5
Silbert, D.6
|